Westrock Coffee Reports Tomorrow With Its Conway Facility Finally Off the Balance Sheet
Westrock Coffee Company (WEST) reports second-quarter fiscal 2026 earnings tomorrow, August 6, before the market opens, with analysts expecting a loss of $0.05 per share. The central question is whether the company can sustain the operational momentum from its strong first quarter—when it delivered a surprise profit and more than tripled adjusted EBITDA—while continuing to reduce leverage and move toward free cash flow positivity in the second half of the year.
Part 1: Earnings Preview
Westrock Coffee Company operates as an integrated coffee, tea, and extract solutions provider, serving retail, foodservice, and convenience store channels through its Beverage Solutions and Sustainable Sourcing & Traceability (SS&T) segments. The company's Conway, Arkansas facility is now fully ramped and cash-flow positive, positioning WEST as a scaled player in the single-serve and packaged coffee markets.
WEST is scheduled to report fiscal Q2 2026 results on August 6, 2026, before the market opens. The consensus estimate calls for a loss of $0.05 per share, with one analyst covering the stock. The company most recently reported Q1 fiscal 2026 earnings of -$0.04 per share, meeting estimates exactly. Compared to the same quarter last year (Q2 fiscal 2025), when WEST posted a loss of $0.12 per share, the current estimate represents 58% improvement year-over-year, reflecting the company's ongoing turnaround trajectory.
Three key themes define this earnings story:
1. Conway Facility Ramp and Operational Leverage: The Conway facility reached full capacity and turned cash-flow positive in Q1, a critical milestone. Investors will watch whether Q2 confirms sustained production efficiency, volume growth (Q1 single-serve cup volumes rose 31%), and continued margin expansion as fixed costs are absorbed across higher output.
2. Path to Free Cash Flow Positivity: Management reaffirmed expectations to achieve free cash flow positivity in the second half of 2026, supported by sharply lower capital expenditures (targeting ~$30M for the full year vs. $89M in 2025). Q2 results will reveal whether working capital management and EBITDA generation are tracking to this goal, particularly as the company navigates seasonal demand patterns.
3. Leverage Reduction and Balance Sheet Health: Secured net leverage improved to 3.45x at the end of Q1 (down from 3.85x at year-end 2025), and liquidity stood at approximately $63 million. With elevated leverage remaining a key risk, investors will scrutinize whether Q2 EBITDA growth and cash generation support further deleveraging, especially as the company pursues its $90–$100 million full-year adjusted EBITDA guidance.
Analyst commentary ahead of the release emphasizes the company's "strong operational and financial progress," citing robust revenue growth, a return to operating profit, and meaningful capital intensity reduction. The strategic partnership with Palantir is highlighted as offering multi-year efficiency upside. However, analysts also note key risks including the remaining GAAP net loss, elevated leverage, dependence on pipeline conversion timing (with single-serve replacement cycles expected late 2026 through end of 2027), and sensitivity to commodity price fluctuations in coffee and gasoline.
Part 2: Historical Earnings Performance
WEST's recent earnings history shows a mixed pattern of beats and misses with significant volatility in surprise magnitude. Over the past four quarters, the company has delivered two in-line results (Q3 and Q1 fiscal 2026, both meeting estimates exactly), one modest beat (Q2 fiscal 2025, beating by 14%), and one substantial miss (Q4 fiscal 2025, missing by 110% with a loss of $0.21 vs. an estimated $0.10 loss).
The trend has improved markedly in recent quarters. After the sharp Q4 miss, WEST returned to meeting estimates in Q1 fiscal 2026 with a $0.04 loss—a significant improvement from the $0.22 loss reported in the prior-year period. This stabilization coincides with the Conway facility reaching full operational capacity and the company's broader turnaround gaining traction. The year-over-year comparison is particularly encouraging: losses have narrowed substantially, from $0.12 in Q2 fiscal 2025 to an expected $0.05 in the upcoming quarter.
The Q4 fiscal 2025 miss stands as an outlier in an otherwise stabilizing trajectory, likely reflecting one-time operational challenges or accounting adjustments during the Conway ramp-up phase. With the facility now cash-flow positive and management reaffirming full-year EBITDA guidance, the recent pattern suggests WEST is building more predictable earnings performance as operational execution improves.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Jun 2025 | $-0.14 | $-0.12 | +14.29% | Beat |
| Sep 2025 | $-0.05 | $-0.05 | unch | Beat |
| Dec 2025 | $-0.10 | $-0.21 | -110.00% | Miss |
| Mar 2026 | $-0.04 | $-0.04 | unch | Beat |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
WEST typically reports earnings before the market opens, meaning Day 0 captures the market's first reaction to results, while Day +1 reflects follow-through trading.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-07 | -$0.17 (-2.80%) | $0.33 (5.44%) | +$2.35 (+39.83%) | $1.75 (29.66%) |
| 2026-03-10 | +$0.16 (+4.12%) | $0.37 (9.54%) | -$0.16 (-3.96%) | $0.45 (11.14%) |
| 2025-11-06 | -$0.34 (-7.98%) | $0.33 (7.75%) | -$0.05 (-1.28%) | $0.57 (14.52%) |
| 2025-08-07 | -$0.33 (-4.72%) | $0.54 (7.65%) | +$0.33 (+4.95%) | $1.12 (16.74%) |
| 2025-05-08 | +$0.05 (+0.82%) | $0.26 (4.26%) | +$1.11 (+18.05%) | $1.62 (26.30%) |
| 2025-03-11 | +$0.16 (+2.49%) | $0.35 (5.38%) | -$0.72 (-10.93%) | $0.63 (9.56%) |
| 2024-11-07 | -$0.12 (-1.62%) | $0.20 (2.70%) | -$0.09 (-1.23%) | $0.72 (9.86%) |
| 2024-08-08 | -$0.22 (-2.30%) | $0.48 (5.02%) | -$0.08 (-0.86%) | $0.82 (8.78%) |
| Avg Abs Move | 3.36% | 5.97% | 10.14% | 15.82% |
Historical price behavior around earnings reveals substantial volatility, with an average absolute Day 0 move of 3.36% and Day +1 move of 10.14%. The most recent earnings release on May 7, 2026, exemplifies this pattern: after a modest 2.80% decline on Day 0, the stock surged 39.83% on Day +1—the largest single-day post-earnings gain in the dataset—following the company's strong Q1 results and reaffirmed guidance.
The direction of moves has been inconsistent, with no clear pattern of bullish or bearish reactions. However, the magnitude of Day +1 moves is notably large, with five of the past eight releases producing Day +1 swings exceeding 10% in absolute terms. The average Day +1 range of 15.82% underscores the stock's tendency for extended volatility in the session following results, suggesting investors should prepare for significant price action regardless of whether the company beats or misses estimates.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 16) |
| Expected Move | $0.00 (0.00%) |
| Expected Range | $8.19 to $8.19 |
| Implied Volatility | 94.00% |
The options market is pricing in an expected move of 0.00% for the August 21 expiration, which appears to be a data anomaly given the stock's historical earnings volatility. Based on the eight-quarter average absolute Day +1 move of 10.14%, investors should anticipate a post-earnings swing significantly larger than what the options market currently reflects.
Part 3: What Analysts Are Saying
Analysts maintain a strongly bullish stance on WEST heading into earnings. The stock carries an average recommendation of 4.60 out of 5.0, with four Strong Buy ratings, zero Moderate Buys, one Hold, and no Sell ratings among the five analysts covering the stock. The consensus 12-month price target of $8.88 implies 8.4% upside from the current price of $8.19, with estimates ranging from a low of $8.00 to a high of $10.00.
Analyst sentiment has remained unchanged over the past month, with the rating distribution and average recommendation holding steady at 4.60. This stability suggests analysts are maintaining conviction in their bullish thesis despite the stock's recent run-up. The tight clustering of price targets—spanning just $2.00 from low to high—indicates relatively strong consensus on valuation, with all analysts seeing at least modest upside from current levels.
The unanimous buy-side tilt (four Strong Buys and one Hold, with no Sell ratings) reflects confidence in WEST's operational turnaround story, particularly the Conway facility's successful ramp, improving EBITDA trajectory, and the path toward free cash flow positivity in the second half of 2026. The single Hold rating provides a minor note of caution, likely reflecting concerns about elevated leverage and execution risk around pipeline conversion timing, but the overwhelming analyst consensus supports the company's transformation narrative.
Part 4: Technical Picture
WEST enters earnings with strong technical momentum across all timeframes. The Barchart Technical Opinion currently stands at 72% Buy, unchanged from last week but strengthened from 56% Buy a month ago, indicating building positive momentum heading into the release.
Timeframe Analysis:
- Short-term (50% Buy): Moderate buy signal suggests near-term momentum is positive but not extreme, leaving room for upside on strong results
- Medium-term (100% Buy): Strong buy signal indicates robust momentum in the intermediate timeframe, reflecting the stock's recovery from earlier lows
- Long-term (100% Buy): Strong buy signal confirms the longer-term uptrend remains intact, supporting the turnaround narrative
Trend Characteristics: The combination of Strong strength and Average direction suggests WEST is in a well-established uptrend with solid momentum, though not yet in overbought territory—a constructive setup for absorbing positive earnings news.
The stock is trading at $8.19, positioned above all major moving averages: the 5-day ($8.15), 10-day ($8.02), 20-day ($7.73), 50-day ($8.09), 100-day ($6.90), and 200-day ($5.66). This alignment with all key moving averages trending higher confirms strong technical support across multiple timeframes.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $8.15 | 50-Day MA | $8.09 |
| 10-Day MA | $8.02 | 100-Day MA | $6.90 |
| 20-Day MA | $7.73 | 200-Day MA | $5.66 |
The stock's position above all moving averages and the strengthening Barchart Opinion over the past month create a technically supportive backdrop for earnings. However, the 50-day moving average at $8.09 sits just below the current price, providing nearby support if results disappoint. With the stock up significantly from its 52-week low of $3.59 and approaching the upper end of its range (52-week high of $10.19), the technical setup suggests the market has already priced in some optimism around the turnaround—meaning execution and guidance will be critical to sustaining momentum. The overall configuration is constructive but leaves limited margin for error.